Development, production, and dissemination of NCI tobacco control monograph
Ended Awarded Last action
- Contract number
- 75N91022F00002
- Awardee
-
Strategix Management LLC UEI JP6YLTEYJLT5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,513,810
Award facts
- Opportunity
-
- 01112022 Solicitation number
- Contract value 100% obligated
- $1,513,810.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Washington, DC 20037, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Change Order | $475,975 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $137,835 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $900,000 |
About this award
The National Cancer Institute awarded a delivery order valued at $1.51M to Strategix Management LLC for the development, production, and dissemination of an NCI Tobacco Control Monograph. This delivery order, issued on August 1, 2022, with an ultimate completion date of May 15, 2026, operates under a cost-plus-fixed-fee pricing structure and does not utilize any set-aside designation. Strategix Management, a Washington, D.C.-based SBA 8(a) certified minority-owned small disadvantaged business, was selected to deliver scientific and technical writing services in support of NCI's tobacco control research initiatives.
This delivery order is issued under Strategix Management's existing $15M single-award Indefinite Delivery Contract with the National Cancer Institute, a competitive 8(a) award through July 2027 for scientific and technical services. The monograph development and dissemination work aligns with NCI's Tobacco Control Research Branch and Division of Cancer Control and Population Sciences mission to advance evidence-based tobacco control strategies and communicate research findings to public health practitioners and policymakers. Strategix Management has demonstrated substantial capability in this domain, having received delivery orders exceeding $8.4M under its NCI IDC for comparable scientific writing, technical support, and monograph development activities.
Quick answers
Who was awarded contract 75N91022F00002?
75N91022F00002 was awarded to Strategix Management LLC by National Cancer Institute (National Institutes of Health) on August 1, 2022.
How much is contract 75N91022F00002 worth?
The government has obligated $1,513,810 on 75N91022F00002.
Is contract 75N91022F00002 an order under another contract?
Yes. 75N91022F00002 is a delivery order under 75N91022D00010, an indefinite delivery contract.
Was contract 75N91022F00002 competed?
The extent of competition for 75N91022F00002 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award